Selegiline reduces daytime sleepiness in patients with Parkinson's disease

OBJECTIVES: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who were given...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Behav
Autors principals: Gallazzi, Marco, Mauri, Marco, Bianchi, Maria Laura, Riboldazzi, Giulio, Princiotta Cariddi, Lucia, Carimati, Federico, Rebecchi, Valentina, Versino, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119812/
https://ncbi.nlm.nih.gov/pubmed/33759401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1880
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars